Cargando…
Using biomarkers to predict treatment response in major depressive disorder: evidence from past and present studies
Major depressive disorder (MDD) is a heterogeneous condition with a variable response to a wide range of treatments. Despite intensive efforts, no biomarker has been identified to date that can reliably predict response or non-response to any form of treatment, nor has one been identified that can b...
Autor principal: | Thase, Michael E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336922/ https://www.ncbi.nlm.nih.gov/pubmed/25733957 |
Ejemplares similares
-
Depression and sleep: pathophysiology and treatment
por: Thase, Michael E.
Publicado: (2006) -
Predictive Biomarkers of Treatment Response in Major Depressive Disorder
por: Stolz, Louise A., et al.
Publicado: (2023) -
A Review of Vilazodone, Serotonin, and Major Depressive Disorder
por: Pierz, Kerri A., et al.
Publicado: (2014) -
Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder
por: Leuchter, Andrew F., et al.
Publicado: (2014) -
Efficacy of vilazodone on anxiety symptoms in patients with major depressive disorder
por: Thase, Michael E., et al.
Publicado: (2014)